JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaked, Y.
Right arrow Articles by Gabizon, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaked, Y.
Right arrow Articles by Gabizon, R.

Journal of Virology, September 2001, p. 7872-7874, Vol. 75, No. 17
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.17.7872-7874.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Copper Binding to the PrP Isoforms: a Putative Marker of Their Conformation and Function

Yuval Shaked, Hana Rosenmann, Nuha Hijazi, Michele Halimi, and Ruth Gabizon*

Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah University Hospital, Jerusalem, Israel

Received 25 January 2001/Accepted 18 May 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

We show here that PrPC, the normal isoform of the prion protein (PrPSc), could be retained by a Cu2+-loaded resin through two different binding sites. Contrarily, PrPSc was not retained at all by such resin. This constitutes a new prion-specific property of PrPSc, which in addition to protease resistance and beta -sheet content, may result from its aberrant conformation.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

PrPC is the normal isoform of PrPSc, the protein component of the prion. Prions cause transmissible neurodegenerative diseases such as scrapie and bovine spongiform encephalopathy as well as Creutzfeldt-Jakob disease in humans (12). The two PrP isoforms have the same amino acid sequence, but in contrast to PrPC, PrPSc comprises a protease-resistant core peptide denominated PrP27-30. The function of PrPC is still unknown, despite the creation and investigation of several lines of PrP0/0 mice (2). The only clue for the function of PrPC is the finding that it binds copper specifically (14, 16).

The established copper binding site on PrP was shown to be comprised in its N-terminal eight tandem repeats (octarepeats) (3). However, Pan et al. (11) showed that when PrPC was purified on a Cu2+-loaded immobilized metal affinity chromatography (IMAC) resin, an N-terminally truncated metabolite of PrPC (called PrPII) was also enriched. This suggests the presence of a second copper binding site on PrP, downstream from the N-terminal repeats. This conclusion, however, should be considered with caution, since in the case of a Cu2+-loaded IMAC resin, the Cu2+ ions are ligated to both the immobilized chelator on the resin and the protein simultaneously, not to the protein only.

In this work, we examined the elution profiles of the PrP isoforms (PrPC and PrPSc) as well as of their metabolites from a Cu2+-loaded IMAC resin at increasing imidazole concentrations. Our results show that as opposed to PrPC and denatured PrPSc, both native PrPSc and PrP27-30 were not retained by the Cu2+-loaded resin. This constitutes a new prion-specific property of PrPSc, which in addition to protease resistance and beta -sheet content, probably results from its aberrant conformation.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

Fifty-microgram aliquots of brain or cells membranes were extracted with 2.5 ml of cold 1% Triton X-100 in phosphate-buffered saline (Triton-PBS) and subsequently mixed for 1 h at room temperature with an IMAC resin which was previously loaded with copper ions as described elsewhere (11). The resin was precipitated by centrifugation, and the nonbound extract was designated the flowthrough. The IMAC resin was washed four times with 2.5 ml of Triton-PBS. The attached proteins were eluted from the resin by the addition of 2.5 ml of imidazole at increasing concentrations (0.05 M twice, 0.1 M twice, and 0.2 M twice). Finally, 2.5 ml of 50 mM EDTA was used (twice) to release the copper ions from the IMAC resin. Other scrapie extracts were denatured with 3 M (final concentration) guanidium isothiocyanate (GuSCN) for 30 min and precipitated with 4 volumes of methanol before resuspension in Triton-PBS and application to the resin. All eluted fractions were recovered by centrifugation of the resin and subsequently immunoblotted with the appropriate antibodies.


    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

A 2% Triton X-100 extract of normal hamster brain membranes was incubated with a Cu2+-loaded IMAC resin and subsequently eluted as described in Materials and Methods. When the eluted fractions were immunoblotted with anti-PrP monoclonal antibody (MAb)3F4 (Fig. 1a), which reacts with residues 108 to 111 in hamster or human PrP (5), only full-length PrP was detected, mostly in the fractions eluted with high imidazole concentrations or EDTA. When the same fractions were immunoblotted with MAb 6H4 (Prionics, Zurich, Switzerland), which reacts with PrP residues 144 to 152 (Fig. 1b), a shorter PrP peptide was also detected, but at the fractions eluted with low imidazole concentrations. These results suggest that this shorter PrP, which did not react with MAb 3F4 and thereby must be truncated at its N terminus, still binds to a Cu2+-loaded IMAC resin, albeit with a lower affinity than full-length PrP. Since, like the PrPII described by Pan et al. (11), it lacks the putative PrP copper binding site present in the N-terminal octarepeats (IMAC1), it must comprise another Cu2+ IMAC retention site (IMAC2).


View larger version (68K):
[in this window]
[in a new window]
 
FIG. 1.   Two copper binding sites on PrPC. (a to c) Triton X-100 extracts from normal hamster brains were applied to and eluted from a Cu2+-loaded IMAC resin as described in Materials and Methods. (a) Flowthrough samples, washes, and eluted samples immunoblotted with anti-PrP MAb 3F4; (b) same samples immunoblotted with MAb 6H4; (c) Triton X-100 extract incubated with the anti-P5 antiserum applied to the resin, eluted as above, and immunoblotted with MAb 6H4; (d) Triton X-100 extracts from mature sperm cells were applied to a Cu2+-loaded IMAC resin. Flowthrough samples, washes, and eluted samples were immunoblotted with anti-PrP MAb 6H4.

Both PrP isoforms are associated with cholesterol-rich membrane microdomains called rafts (9, 15). To establish whether PrPC binds directly to the Cu2+-loaded resin or is attached to it through a neighbor raft protein, the normal Triton X-100 extract was incubated with the anti-PrP antiserum (reacting against residues 142 to 172) (1) before being applied to the IMAC resin. In the presence of this antiserum (Fig. 1c), the N-terminally truncated PrP was eluted mostly in the flowthrough, while full-length PrP was eluted at considerable lower imidazole concentrations, suggesting that the anti-PrP antiserum lowered the affinity of PrP peptides to the Cu2+-loaded IMAC resin. These results indicate that PrPC binds to the copper-loaded resin directly, but although suggestive, they do not prove that the IMAC2 retention site lies between residues 142 and 174, since the antibody may also hinder the binding of copper to a nearby site of the protein. As expected from previous results (11), an IMAC resin loaded with zinc did not show any specific PrP retention (not shown).

We have shown recently that in mature sperm cells, PrP is truncated at its C terminus, probably between the two PrP N-glycosylation sites (residues 181 and 197) (13). Human ejaculates containing mature sperm cells were extracted in Triton X-100, applied to a Cu2+-loaded IMAC resin, and eluted as described above for brain extracts. All sperm PrP, which comprises the N-terminal but not the C-terminal part of PrP, was retained by the copper resin and eluted at low imidazole concentrations (Fig. 1d). These results indicate that the additional Cu2+ retention site may reside in the C-terminal part of PrP.

To determine whether PrPSc and PrP27-30 can be retained by a Cu2+-loaded IMAC resin, membranes from scrapie-infected hamster brains were extracted with Triton X-100 and applied to an IMAC resin as described for normal brain membranes. PrPSc molecules aggregate in the presence of detergents such as Sarkosyl (7), but this is not the case for scrapie-infected membranes extracted in cold Triton X-100, in which PrPSc is still incorporated into rafts and therefore does not aggregate (8).

Compared to normal brain membranes (Fig. 2a), most of the total PrP present in the extract (PrPC and PrPSc) was found in the flowthrough and not in any of the retained fractions (Fig. 2b). Moreover, all PrP was detected in the flowthrough when the samples were digested with proteinase K (PK) before immunoblotting (Fig. 2c) or when the Triton X-100 scrapie-infected extract was digested with PK before application to the Cu2+-loaded IMAC resin (Fig. 2d). These results suggest that both PrPSc and PrP27-30 did not bind to a Cu2+-loaded IMAC resin. When the scrapie membranes were first denatured by 3 M GuSCN, the PrP protein was retained by the resin at the same fashion as PrPC, suggesting the difference in retention of PrPC and PrPSc by a Cu2+-loaded IMAC resin results from the aberrant conformation of PrPSc (Fig. 2e). Similar results were obtained previously for sodium dodecyl sulfate-denatured PrPSc (4). The fact that only a small fraction of total PrP molecules were retained by the Cu2+-loaded IMAC resin before PK digestion suggests that the concentration of functional PrPC is very low in extracts from scrapie-infected brains. These results are consistent with those presented in a recent publication suggesting that specific anti-PrPC antibodies react very poorly with scrapie-infected brain samples (17).


View larger version (92K):
[in this window]
[in a new window]
 
FIG. 2.   PrPSc and PrP27-30 do not bind copper. Triton X-100 extracts from normal and scrapie-infected hamster brains were applied to and eluted from a Cu2+-loaded IMAC resin as described in Materials and Methods and the legend to Fig. 1. Before immunoblotting, the eluted scrapie brain samples were digested in the presence and absence of PK (50 µg/ml). Part of the scrapie extracts were digested with PK before the application to the resin. (a) Normal hamster brain; (b) scrapie-infected hamster brain; (c) scrapie samples digested with PK before immunoblotting; (d) scrapie samples digested with PK before application to the Cu2+-loaded IMAC resin; (e) scrapie samples after denaturation with 3 M GuSCN. Panels a and b were immunoblotted with MAb 3F4; panels c to e were immunoblotted with MAb 6H4.

The fact that PrPSc, as opposed to PrPC, does not bind to a Cu2+-loaded IMAC resin constitutes a newly identified difference between the two prion protein isoforms, which until now were distinguished mostly by their protease resistance and beta -sheet content (6, 10). That full-length PrPSc is not retained by a Cu2+-loaded IMAC resin may be specifically important, since it suggests that also the N-terminal part of PrPSc, which is not protease resistant and does not present a beta -sheet structure, may differ in conformation from the N-terminal part of PrPC. It will be interesting to test the Cu2+-loaded IMAC resin retention properties of pathogenic mutant PrPs before they acquire protease resistance to determine whether they resemble PrPC or PrPSc.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Neurology, Hadassah University Hospital, Jerusalem, Israel 91120. Phone: 972-2-6777858. Fax: 972-2-6429441. E-mail: gabizonr{at}hadassah.org.il.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results and Discussion
References

1. Barry, R. A., M. T. Vincent, S. B. Kent, L. E. Hood, and S. B. Prusiner. 1988. Characterization of prion proteins with monospecific antisera to synthetic peptides. J. Immunol. 140:1188-1193[Abstract].
2. Bueler, H., M. Fischer, Y. Lang, H. Bluethmann, H. P. Lipp, S. J. DeArmond, S. B. Prusiner, M. Aguet, and C. Weissmann. 1992. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 356:577-582[CrossRef][Medline].
3. Hornshaw, M. P., J. R. McDermott, and J. M. Candy. 1995. Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem. Biophys. Res. Commun. 207:621-629[CrossRef][Medline].
4. Ishikawa, Y., S. Ito, S. Nishino, S. Ohba, and Y. Nishida. 1998. Contribution of a peroxide adduct of copper(II)-peptide complex to modify the secondary structure of albumin. Z. Naturforsch. C 53:378-382.
5. Kascsak, R. J., R. Rubenstein, P. A. Merz, M. Tonna DeMasi, R. Fersko, R. I. Carp, H. M. Wisniewski, and H. Diringer. 1987. Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J. Virol. 61:3688-3693[Abstract/Free Full Text].
6. McKinley, M. P., D. C. Bolton, and S. B. Prusiner. 1983. A protease-resistant protein is a structural component of the scrapie prion. Cell 35:57-62[CrossRef][Medline].
7. McKinley, M. P., R. K. Meyer, L. Kenaga, F. Rahbar, R. Cotter, A. Serban, and S. B. Prusiner. 1991. Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis. J. Virol. 65:1340-1351[Abstract/Free Full Text].
8. Naslavsky, N., R. Stein, A. Yanai, G. Friedlander, and A. Taraboulos. 1997. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 272:6324-6331[Abstract/Free Full Text].
9. Naslavsky, N., R. Stein, A. Yanai, G. Friedlander, S. B. Prusiner, and A. Taraboulus. 1997. Characterization of detergent-insoluble complexes containing the cellular prion protein and its scrapie isoform. J. Biol. Chem. 272:6324-6331.
10. Pan, K. M., M. Baldwin, J. Nguyen, M. Gasset, A. Serban, D. Groth, I. Mehlhorn, Z. Huang, R. J. Fletterick, F. E. Cohen, et al. 1993. Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc. Natl. Acad. Sci. USA 90:10962-10966[Abstract/Free Full Text].
11. Pan, K. M., N. Stahl, and S. B. Prusiner. 1992. Purification and properties of the cellular prion protein from Syrian hamster brain. Protein Sci. 1:1343-1352[Abstract].
12. Prusiner, S. B. 1998. Prions. Proc. Natl. Acad. Sci. USA 95:13363-13383[Abstract/Free Full Text].
13. Shaked, Y., H. Rosenmann, G. Talmor, and R. Gabizon. 1999. A C-terminal-truncated PrP isoform is present in mature sperm. J. Biol. Chem. 274:32153-32158[Abstract/Free Full Text].
14. Stockel, J., J. Safar, A. C. Wallace, F. E. Cohen, and S. B. Prusiner. 1998. Prion protein selectively binds copper(II) ions. Biochemistry 37:7185-7193[CrossRef][Medline].
15. Taraboulos, A., M. Scott, A. Semenov, D. Avrahami, L. Laszlo, S. B. Prusiner, and D. Avraham. 1995. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J. Cell Biol. 129:121-132[Abstract/Free Full Text].
16. Viles, J. H., F. E. Cohen, S. B. Prusiner, D. B. Goodin, P. E. Wright, and H. J. Dyson. 1999. Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc. Natl. Acad. Sci. USA 96:2042-2047[Abstract/Free Full Text].
17. Yokoyama, T., K. M. Kimura, Y. Ushiki, S. Yamada, A. Morooka, T. Nakashiba, T. Sassa, and S. Itohara. 2001. In vivo conversion of cellular prion protein to pathogenic isoforms, as monitored by conformation-specific antibodies. J. Biol Chem. 276:11265-11271[Abstract/Free Full Text].


Journal of Virology, September 2001, p. 7872-7874, Vol. 75, No. 17
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.17.7872-7874.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shaked, Y.
Right arrow Articles by Gabizon, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shaked, Y.
Right arrow Articles by Gabizon, R.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS